Sol-Gel gets FDA approval for encapsulated skin disease drug
Sol-Gel Technologies’ work to expand the treatment options for patients with the skin condition rosacea has paid off, with the FDA approving a product based on its microencapsulation technology. Galderma will commercialize the topical medicine, Epsolay, in the U.S.